Nahdi Medical Company
4164
Peringkat dalam Saham
#4861
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Harga Saham
$23.42
Kapitalisasi Pasar
$3.05B
Perubahan (1 hari)
-0.45%
Perubahan (1 tahun)
-27.09%
Negara
SA
Perdagangan Nahdi Medical Company (4164)
Kategori
Healthcare
Laba untuk Nahdi Medical Company (4164)
Laba pada Jun 2026 TTM: $217.74M
Menurut laporan keuangan terbaru dari Nahdi Medical Company, laba saat ini perusahaan adalah $217.74M. Pada tahun 2023, perusahaan memperoleh laba sebesar $251.81M, peningkatan dibandingkan laba tahun 2022 sebesar $249.53M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Nahdi Medical Company dari 2017 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $217.74M | -1.98% |
| 2024 | $222.14M | -11.78% |
| 2023 | $251.81M | 0.91% |
| 2022 | $249.53M | 9.27% |
| 2021 | $228.35M | -4.23% |
| 2020 | $238.42M | 16.36% |
| 2019 | $204.91M | 20.34% |
| 2018 | $170.27M | -15.09% |
| 2017 | $200.53M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $1.35B | 519.94% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $26.37M | -87.89% |
US
|
